Compare Canopy Growth Corp (CGC) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs DexCom, Inc. — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $407.38M), while DexCom, Inc. trades at $76.3 (market cap $29.46B). The key difference: DexCom, Inc. is far larger — about 72.3× Canopy Growth Corp's market cap, and DexCom, Inc. is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | DXCM | |
|---|---|---|
Market Cap | $407.38M | $29.46B |
Sector | Health | Health |
52-Week High | $1.92 | $89.53 |
52-Week Low | $0.86 | $54.84 |
Enterprise Value | $346.82M | $28.43B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
